1'-(tert-Butyl) 1-ethyl 4-(iodomethyl)-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1,1'-dicarboxylate

Catalog No. :
ACGSBQ674
CAS No. :
2225141-25-1
Molecular Formula :
C18H28INO5
Molecular Weight :
465.33

IUPAC Name:1'-(tert-butyl) 1-ethyl 4-(iodomethyl)-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1,1'-dicarboxylate

1'-(tert-Butyl) 1-ethyl 4-(iodomethyl)-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1,1'-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$323.00Login to see priceInquiryInquiry
100mg98%$473.00Login to see priceInquiryInquiry
250mg98%$669.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1'-(tert-Butyl) 1-ethyl 4-(iodomethyl)-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1,1'-dicarboxylate
IUPAC Name1'-(tert-butyl) 1-ethyl 4-(iodomethyl)-3-oxaspiro[bicyclo[2.1.1]hexane-2,4'-piperidine]-1,1'-dicarboxylate
Molecular FormulaC18H28INO5
Molecular Weight465.33
SMILESCCOC(=O)C12CC(CI)(C1)OC21CCN(C(=O)OC(C)(C)C)CC1
InChI KeyPHURLNZOKMQIRZ-UHFFFAOYSA-N
Synonym1''-tert-butyl 1-ethyl 4-(iodomethyl)-3-oxaspiro[bicyclo[2.1.1]hexane-2,4''-piperidine]-1,1''-dicarboxylate;Spiro[2-oxabicyclo[2.1.1]hexane-3,4'-piperidine]-1',4-dicarboxylic acid, 1-(iodomethyl)-, 1'-(1,1-dimethylethyl) 4-ethyl ester
CAS No.2225141-25-1

Synthetic Route by SureRoute

1. ACGSBQ674 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGSBQ674 route product structure diagram
    ACGSBQ6742225141-25-1
Inquiry

2. ACGSBQ674 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGSBQ674 route product structure diagram
    ACGSBQ6742225141-25-1
Inquiry

Comments (0)